OPKO HEALTH INC (OPK)
US68375N1037 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.775B 23.64% | 1.004B -43.42% | 863.495M -14.01% | 691.76M -19.89% | 691.77M 0.00% | 741.46M 7.18% | |
| EBITDA YoY % growth | 66M -54.20% | -136.2M -306.36% | -51.724M 62.02% | -83.477M -61.39% | 1.313M 101.57% | 52.369M 3,888.50% | |
| EBIT YoY % growth | -12.7M -121.64% | -244.9M -1,828.35% | -157.021M 35.88% | -187.173M -19.20% | -194.706M -4.02% | -68.047M 65.05% | |
| Operating Margin | -0.72% | -24.39% | -18.18% | -27.06% | -28.15% | -9.18% | |
| EPS YoY % growth | -0.07 -240.00% | -0.44 -528.57% | -0.25 44.07% | -0.19 24.48% | -0.29 -56.70% | -0.11 61.85% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 10.22% | -0.08 34.77% | -0.07 -632.25% | -0.07 21.44% | -0.07 15.62% | -0.06 22.58% | -0.06 17.24% | -0.06 14.29% | -0.05 25.93% |
| Revenue Q2Q % growth | 156.97M -13.71% | 157.93M -9.08% | 164.23M -9.86% | 168.04M 38.57% | 176.66M 12.54% | 168.3M 6.57% | 172.08M 4.78% | 169.47M 0.85% | 180.55M 2.20% |
| EBITDA Q2Q % growth | -13.686M -137.75% | -6.262M 86.28% | -3.434M 70.64% | -909K 97.26% | 2.323M 116.97% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -59.578M 13.71% | -50.984M 28.67% | -48.113M 21.98% | -47.84M 55.40% | -45.369M 23.85% | -44.319M 13.07% | -40.238M 16.37% | -37.673M 21.25% | -34.744M 23.42% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 18.18% | -0.09 | 0.00 | 4.52% |
| Q2 2024 Q2Q % growth | -0.01 61.64% | -0.10 | 0.09 | 89.58% |
| Q1 2024 Q2Q % growth | -0.12 -500.00% | -0.10 | -0.02 | -25.07% |
| Q4 2023 Q2Q % growth | -0.09 18.18% | -0.09 | 0.00 | -1.26% |
| Q3 2023 Q2Q % growth | -0.11 | -0.10 | -0.01 | -8.91% |
| Q2 2023 Q2Q % growth | -0.03 81.38% | -0.07 | 0.05 | 63.99% |
| Q1 2023 Q2Q % growth | -0.02 75.00% | -0.08 | 0.06 | 74.17% |
| Q4 2022 Q2Q % growth | -0.11 | -0.11 | 0.00 | 3.90% |
| Q3 2022 Q2Q % growth | -0.11 | -0.08 | -0.03 | -29.66% |
| Q2 2022 Q2Q % growth | -0.14 -1,300.00% | 0.01 | -0.15 | -1,832.67% |
| Q1 2022 Q2Q % growth | -0.08 -260.00% | -0.06 | -0.02 | -41.44% |
| Q4 2021 Q2Q % growth | -0.11 -320.00% | -0.02 | -0.09 | -444.55% |
| Q3 2021 Q2Q % growth | 0.00 -100.00% | -0.01 | 0.01 | 100.00% |
| Q2 2021 Q2Q % growth | -0.01 -120.00% | 0.02 | -0.03 | -155.01% |
| Q1 2021 Q2Q % growth | 0.05 155.56% | 0.05 | 0.00 | 3.14% |
| Q4 2020 Q2Q % growth | 0.05 266.67% | 0.04 | 0.01 | 17.87% |
| Q3 2020 Q2Q % growth | 0.04 136.36% | 0.04 | 0.00 | -9.99% |
| Q2 2020 Q2Q % growth | 0.05 150.00% | -0.07 | 0.12 | 175.01% |
| Q1 2020 Q2Q % growth | -0.09 30.77% | -0.09 | 0.00 | -0.40% |
| Q4 2019 Q2Q % growth | -0.03 | -0.09 | 0.06 | 66.15% |
| Q3 2019 Q2Q % growth | -0.11 | -0.09 | -0.02 | -21.01% |
| Q2 2019 Q2Q % growth | -0.10 | -0.11 | 0.01 | 12.64% |
| Q1 2019 Q2Q % growth | -0.13 | -0.09 | -0.04 | -48.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 121.271M -32.10% | 183.34M | -62.069M | -33.85% |
| Q2 2024 Q2Q % growth | 182.186M -31.35% | 187.04M | -4.854M | -2.60% |
| Q1 2024 Q2Q % growth | 173.7M -26.89% | 184.82M | -11.12M | -6.02% |
| Q4 2023 Q2Q % growth | 181.9M -1.83% | 179.31M | 2.59M | 1.44% |
| Q3 2023 Q2Q % growth | 178.6M -0.61% | 176.53M | 2.07M | 1.17% |
| Q2 2023 Q2Q % growth | 265.4M -14.36% | 203.99M | 61.41M | 30.10% |
| Q1 2023 Q2Q % growth | 237.6M -27.83% | 195.29M | 42.31M | 21.67% |
| Q4 2022 Q2Q % growth | 185.3M -53.83% | 169.89M | 15.41M | 9.07% |
| Q3 2022 Q2Q % growth | 179.7M -53.42% | 185.35M | -5.65M | -3.05% |
| Q2 2022 Q2Q % growth | 309.9M -29.95% | 330.14M | -20.24M | -6.13% |
| Q1 2022 Q2Q % growth | 329.2M -39.62% | 335.94M | -6.74M | -2.01% |
| Q4 2021 Q2Q % growth | 401.3M -18.88% | 333.13M | 68.17M | 20.46% |
| Q3 2021 Q2Q % growth | 385.8M -9.88% | 305.29M | 80.51M | 26.37% |
| Q2 2021 Q2Q % growth | 442.4M 46.88% | 460.92M | -18.52M | -4.02% |
| Q1 2021 Q2Q % growth | 545.2M 157.78% | 500.09M | 45.11M | 9.02% |
| Q4 2020 Q2Q % growth | 494.7M 120.55% | 447.53M | 47.17M | 10.54% |
| Q3 2020 Q2Q % growth | 428.1M 87.11% | 382.45M | 45.65M | 11.94% |
| Q2 2020 Q2Q % growth | 301.2M 33.04% | 248.06M | 53.14M | 21.42% |
| Q1 2020 Q2Q % growth | 211.5M -4.94% | 219.03M | -7.53M | -3.44% |
| Q4 2019 Q2Q % growth | 224.3M | 218.24M | 6.06M | 2.78% |
| Q3 2019 Q2Q % growth | 228.8M | 227.65M | 1.15M | 0.51% |
| Q2 2019 Q2Q % growth | 226.4M | 227.32M | -920K | -0.40% |
| Q1 2019 Q2Q % growth | 222.5M | 243.68M | -21.18M | -8.69% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 7.7% | 10.68% | 39.01% |
| Revenue | 0% | -21.99% | -0.35% | -2.88% |